2. Definition
• It’s a malignant clonal disorders originating from hematopoietic stem
cells characterized by the proliferation of poorly differentiated blast
( immature )cells in the bone marrow & rapidly progressive to fatal
course if untreated
• Survival < 6 months without treatment
• Also k/w acute myelogenous leukemia, acute nonlymphocytic
leukemia
7. Pathogenesis
•Recurrent genetic aberrations of transcription factors which
required for normal myeloid differentiation
•Most common chromosomal rearrangements t(8;21) &
inv (16) which disrupts the RUNX1 & CBFB genes respectively
•t(15;17) – RARA/PML fusion gene rearrangement
8. Clinical features
1. Most common in adults
2. Median age is 65
3. Anemia – weakness, fatigue
4. Granulocytopenia – infections
5. Thrombocytopenia – bleeding tendencies
6. Bone pain
7. Hepatomegaly less common
8. Splenomegaly
9. Lymphadenopathy rare
•Gum
hypertrophy
M4,M5
•DIC – M3
9. Morphology
• 20% blast cells in the bone marrow
• Myeloblast:
• Delicate nuclear chromatin
• Two to four nucleoli
• Abundant cytoplasm than lymphoblast
• Cytoplasm contain fine peroxidase positive azurophilic granules
• Auer rods – distinctive needle like azurophilic granules
• Monoblast:
• Folded or lobulated nuclei
• Lack Auer rods
• Nonspecific esterase positive
• Occasionally blasts are entirely absent ( Aleukemic leukemia)
10.
11.
12.
13.
14.
15. Investigations
• Peripheral smear:
• Anemia – Normocytic Normochromic
• TLC – Low or markedly raised
• Platelets – Reduced & often large , bizarre
• Bone marrow:
• 20% or more blasts in all nucleated cells in the marrow
• Hyper cellular
• Immunophenotype:
• Positive for CD 33, 34
• Cytochemistry:
• Myeloperoxidase positive ( M1,M2,M3,M4)
• Nonspecific esterase positive ( M4,M5)